JUNGLA
Headquartered in South San Francisco, Jungla is a biotechnology company delivering robust and scalable results for clinical genetic and genomic testing. To achieve this, Jungla develops and combines advances in functional genomics, computational biophysics, and computer science to proactively inform on the risk of variants in our genome. Jungla aims to empower clinical genetic testing with quantitative, model-driven guidance to complement and enhance observational data. Whereas existing solutions routinely used in the market have demonstrably poor accuracies, Jungla delivers robust, scalable, and auditable support with dramatically higher accuracies and increasingly mechanistic cellular and biophysical insights. We are supported by leading technology and healthcare investors.
JUNGLA
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.jungla.bio
Total Employee:
1+
Status:
Active
Total Funding:
2.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag
Current Advisors List
Advisor
2016-12-01
Founder
Investors List
Andreessen Horowitz
Andreessen Horowitz investment in Seed Round - Jungla
SOSV
SOSV investment in Seed Round - Jungla
IndieBio
IndieBio investment in Seed Round - Jungla
IndieBio
IndieBio investment in Pre Seed Round - Jungla
SOSV
SOSV investment in Pre Seed Round - Jungla
Newest Events participated
Official Site Inspections
http://www.jungla.bio
- Host name: any-in-2615.1e100.net
- IP address: 216.239.38.21
- Location: Mexico City Mexico
- Latitude: 19.3421
- Longitude: -99.1927
- Timezone: America/Mexico_City
- Postal: 01090
More informations about "Jungla"
Jungla Inc. (2016-2019): Welcome
In this manner, Jungla places the data from each patient at the service of the next and provides robust, quantitative, and transparent clinical guidance. Clear, Coherent Diagnostic Value …See details»
Jungla - Crunchbase Company Profile & Funding
Headquartered in South San Francisco, Jungla is a biotechnology company delivering robust and scalable results for clinical genetic and genomic testing. To achieve this, Jungla develops and …See details»
Jungla Inc. (2016-2019): Team
Jungla was founded by team of leading experts in genomics, biophysics, cellular modeling, and technology development from Stanford University. As pioneers in large-scale molecular and …See details»
Invitae - Invitae to Acquire Jungla to Advance Genetic Variant ...
Jul 11, 2019 For further information, visit jungla.bio. About Invitae Invitae Corporation is a leading medical genetics company, whose mission is to bring comprehensive genetic …See details»
Jungla Inc. - IndieBio - #1 in Early Stage Biotech
Jungla.bio * Data source: Crunchbase. Carlos Araya, PhD, CEO. At Jungla, we are continuously applying and combining advances in molecular, cellular, and computational technologies to the complex work of genetic variant …See details»
Jungla - SOSV
Headquartered in South San Francisco, Jungla is a biotechnology company delivering robust and scalable results for clinical genetic and genomic testing. To achieve this, Jungla develops and combines advances in functional genomics, …See details»
Jungla Company Profile - Office Locations, Competitors ... - Craft
Jungla is an AI-driven biotechnology company enabling clinical guidance across genetic and genomic tests. It develops Molecular Evidence Platform (MEP), an active learning engine that …See details»
Jungla - VentureRadar
Bio tech-Careers. Jungla's Molecular Evidence Platform (MEP) is an active learning engine that continuously integrates clinical knowledge to systematically generate, evaluate, audit, and …See details»
Jungla Inc. (2016-2019): Our Work
Jungla's solutions demonstrate prospective accuracy against clinical test results from leading providers and deliver performance that exceeds recommendations from the American College …See details»
Jungla, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Jungla, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Jungla CEO and Key Executive Team | Craft.co
Jungla's Cofounder, Lead of Technical Development is Alex Colavin. Other executives include Carlos Araya, Cofounder, CEO; Jason Reuter, Cofounder, Lead of Functional Genomics and 2 …See details»
About – Jungla Inc. – Medium
Jungla Inc. is an AI-driven biotechnology company empowering precision medicine with accurate, quantitative, scalable genetic and genomic tests. [ jungla.bio ]. Open in appSee details»
Jungla, Inc. - CoBee Company Profile & Funding Rounds
Jungla.bio Jungla, Inc. Jungla develops AI-based computational and cellular modeling to improve clinical genetic tests in the healthcare industry. Business Model: ... Jungla develops AI-based …See details»
Jungla 2025 Company Profile: Valuation, Investors, Acquisition
Jungla General Information Description. Developer of a molecular function software platform created to optimize disease diagnosis and treatment. The company's platform helps in the …See details»
Jungla and Unknown Significance - Medium
Aug 5, 2019 We funded Jungla, to build out the algorithm and data platform and achieve customer traction, all in four months. IndieBio HQ in downtown San Francisco. Carlos and …See details»
Jungla | Biotech Careers
Jungla's Molecular Evidence Platform (MEP) is an active learning engine that continuously integrates clinical knowledge to systematically generate, evaluate, audit, and distribute …See details»
Nextsource | Company Profile | Jungla
Uncover shifts in customer sentiment around Jungla through recent reviews or social media mentions. Track key 'champions' at Jungla as they move through different departments or take …See details»
Jungla Inc. (2016-2019): News & Media
By Carlos L. Araya, CEO & Cofounder, Jungla Inc. November 26, 2018 –– South San Francisco, California HPE Discover: Reimagining Medical Testing through Memory-Driven Computing & …See details»
Jungla - Biotech Careers
Jungla's Molecular Evidence Platform (MEP) is an active learning engine that continuously integrates clinical knowledge to systematically generate, evaluate, audit, and distribute …See details»
New survey: U.S. biotechs warn tariffs could impede access to …
2 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the …See details»